EVAX Earnings Date & History
Evaxion A/S (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 4:06 PM ET
Evaxion A/S
Biotechnology
- Next earnings date
- Thursday, August 20, 2026
- Reporting session
- Before Open
- EPS estimate
- $-0.32
- Revenue estimate
- $0
EVAX earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Thursday, May 7, 2026 | Q1 2026 | $-0.31 | $-0.50 | -61.6% | $0 |
| Thursday, March 5, 2026 | Q4 2025 | $-0.30 | $-1.00 | -230.5% | $0 |
| Thursday, November 6, 2025 | Q3 2025 | $0.41 | $0.50 | +22.5% | $7.5M |
| Thursday, August 14, 2025 | Q2 2025 | $-0.67 | $-1.00 | -48.5% | $37,000 |
What the market is watching in EVAX's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next EVAX earnings date?
- Evaxion A/S is scheduled to report on Thursday, August 20, 2026 (Before Open). Dates can change until the company confirms them.
- Does EVAX report before or after the market?
- The next report is scheduled before open.
- What EPS is expected for EVAX?
- Consensus EPS for the upcoming quarter is $-0.32, on revenue of $0.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
EVAX earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.